Early studies on Alzheimer’s Disease patients showed that CD36 is highly expressed in cortical samples of AD patients and cognitively normal subjects with the presence of amyloid plaques compared with amyloid-free controls (Ricciarelli et al., 2004). The gene discussed is CD36; the disease is Alzheimer disease.